Clinical Trial Update: Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating progression-free survival for patients with stage II A/B seminomatous testicular germ cell tumors treated with primary retroperi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Testicular Germ Cell Tumor

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Stage II A/B Seminomatous Germ Cell Tumors | Phase 2 | Status: UNKNOWN